What is LNSR's current stock price?

LNSR (LENSAR, Inc.) is currently trading at $6.09 with a market cap of $73.7M.

What sector is LENSAR, Inc. in?

LENSAR, Inc. (LNSR) operates in the Healthcare sector, specifically in the Medical - Devices industry.

Is LNSR a good stock to buy?

Analysts have a Buy consensus on LNSR with a price target of $10.00. Check our detailed analysis for valuation, financials, and insider activity.

InvestLog

LNSR LENSAR, Inc.

Healthcare

$6.09+2.35%ClosedMarket Cap: $73.7M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

3.01

P/S

1.28

EV/EBITDA

-7.85

DCF Value

$-48.39

FCF Yield

-16.6%

Div Yield

0.0%

Margins & Returns

Gross Margin

45.3%

Operating Margin

-28.7%

Net Margin

50.9%

ROE

-514.9%

ROA

44.4%

ROIC

-33.6%

Financials

View All

Period	Revenue	Net Income	EPS
Q1 null	$13.4M	$36.3M	$—
Q4 null	$16.0M	$-1.5M	$—
FY null	$58.4M	$-34.3M	$—
Q3 null	$14.3M	$-3.7M	$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$10.00

Target (Median)

$10.00

Target Range

$10.00 - $10.00

0 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell

BTIGBuy

2026-03-18

Trading Activity

Insider Trades

View All

Wong Kendraofficer: Principal Accounting Officer

SellFri May 08

STAAB THOMAS R IIofficer: Chief Financial Officer

SellFri May 08

CURTIS NICHOLAS Tdirector, officer: Chief Executive Officer

SellFri May 08

Connaughton Alan B.officer: Chief Operating Officer

SellFri May 08

STAAB THOMAS R IIofficer: Chief Financial Officer

SellThu Mar 19

Company Info

Sector

Healthcare

Industry

Medical - Devices

Country

Exchange

—

Beta

0.84

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.

Peers

AVR